Showing results (211-220 of 250) with videos related to
Sort By:
Pageof 25
NPJ Breast Cancer|August 30, 2018
Sentinel lymph node B cells can predict disease-free survival in breast cancer patientsKim R M Blenman, Ting-Fang He, Paul H Frankel, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 23, 2017
Tumor Uptake of 64Cu-DOTA-Trastuzumab in Patients with Metastatic Breast CancerJoanne E Mortimer, James R Bading, Jinha M Park, et al.Plos One|November 7, 2019
Mutation and immune profiling of metaplastic breast cancer: Correlation with survivalMichelle Afkhami, Daniel Schmolze, Susan E Yost, et al.Psychotherapy and Psychosomatics|January 1, 1978
Treatment of anxiety: a comparison of the usefulness of self-hypnosis and a meditational relaxation technique. An overviewH Benson, F H Frankel, R Apfel, et al.Cancer|December 14, 2022
Phase 2 prospective open label study of neoadjuvant nab-paclitaxel, trastuzumab, and pertuzumab in patients with HER2-positive primary breast cancerSayeh M Lavasani, George Somlo, Susan E Yost, et al.Cancer Letters|December 29, 2014
Baicalein upregulates DDIT4 expression which mediates mTOR inhibition and growth inhibition in cancer cellsYujun Wang, Ernest Han, Quanhua Xing, et al.Frontiers in Oncology|March 28, 2019
Phase II Trial of Cabozantinib Plus Erlotinib in Patients With Advanced Epidermal Growth Factor Receptor (EGFR)-Mutant Non-small Cell Lung Cancer With Progressive Disease on Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy: A California Cancer Consortium Phase II Trial (NCI 9303)Karen L Reckamp, Paul H Frankel, Nora Ruel, et al.The Journal of Trauma|March 1, 1996
Subcutaneous tissue oxygen pressure: a reliable index of peripheral perfusion in humans after injuryW Drucker, F Pearce, L Glass-Heidenreich, et al.BMC Nephrology|January 4, 2022
Management of hypertension and renin-angiotensin-aldosterone system blockade in adults with diabetic kidney disease: Association of British Clinical Diabetologists and the Renal Association UK guideline update 2021D Banerjee, P Winocour, T A Chowdhury, et al.Cancers|September 9, 2022
Phase II Study Combining Pembrolizumab with Aromatase Inhibitor in Patients with Metastatic Hormone Receptor Positive Breast CancerXuan Ge, Susan E Yost, Jin Sun Lee, et al.Pageof 25